Calidi Biotherapeutics In... (CLDI)
AMEX: CLDI
· Real-Time Price · USD
5.26
0.22 (4.37%)
At close: Aug 15, 2025, 3:49 PM
4.37% (1D)
| Bid | 5.25 |
| Market Cap | 15.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -21.57M |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -26.32 |
| Forward PE | -0.91 |
| Analyst | Buy |
| Ask | 5.27 |
| Volume | 73,075 |
| Avg. Volume (20D) | 1,470,363 |
| Open | 5.26 |
| Previous Close | 5.04 |
| Day's Range | 5.01 - 5.39 |
| 52-Week Range | 2.44 - 46.68 |
| Beta | 1.16 |
About CLDI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLDI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLDI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+14.85%
Calidi Biotherapeutics shares are trading higher a...
Unlock content with
Pro Subscription
2 weeks ago
-24.66%
Calidi Biotherapeutics shares are trading lower after the company announced a 1-for-12 reverse stock split.
1 week ago · fool.com
Calidi Loss Down 23 Percent in Fiscal Q2Calidi Loss Down 23 Percent in Fiscal Q2
